Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model (Q39270988)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model |
scientific article |
Statements
1 reference
Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model (English)
1 reference
Elisabeth G E de Vries
1 reference
Arne R M van der Bilt
1 reference
Anton G T Terwisscha van Scheltinga
1 reference
Hetty Timmer-Bosscha
1 reference
Carolien P Schröder
1 reference
Linda Pot
1 reference
Jos G W Kosterink
1 reference
Ate G J van der Zee
1 reference
Marjolijn N Lub-de Hooge
1 reference
Steven de Jong
1 reference
Anna K L Reyners
1 reference
26 September 2012
1 reference
1 reference
Identifiers
1 reference